Geneos Therapeutics reported raising $5 Million in an initial SEC Form D filing, from an offering of $10 Million
Round Type
Series A
Plymouth MeetingBiotechnologyHealth CareScience And EngineeringWho else raised in Science And Engineering and Biotechnology around the same time
Companies in the same sectors as Geneos Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Ray Therapeutics raised $14M on May 15, 2023.
- Wheeler Bio raised $31M (Series A) on April 13, 2023.
- 22nd Century raised $21M (Debt Financing) on March 3, 2023.
- Aprea Therapeutics raised an undisclosed amount (Funding Round) on February 28, 2023.
- Sorrento Therapeutics raised $75M (Funding Round) on February 21, 2023.
- U.S. Renal Care raised $328M (Funding Round) on May 15, 2023.
Who to call at Geneos Therapeutics, and when
A new round usually means Geneos Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Geneos Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Geneos Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Geneos Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Geneos Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansGeneos Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.